» Articles » PMID: 12482908

Making Sense of Latent TGFbeta Activation

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2002 Dec 17
PMID 12482908
Citations 723
Authors
Affiliations
Soon will be listed here.
Abstract

TGFbeta is secreted as part of a latent complex that is targeted to the extracellular matrix. A variety of molecules, 'TGFbeta activators,' release TGFbeta from its latent state. The unusual temporal discontinuity of TGFbeta synthesis and action and the panoply of TGFbeta effects contribute to the interest in TGF-beta. However, the logical connections between TGFbeta synthesis, storage and action are obscure. We consider the latent TGFbeta complex as an extracellular sensor in which the TGFbeta propeptide functions as the detector, latent-TGFbeta-binding protein (LTBP) functions as the localizer, and TGF-beta functions as the effector. Such a view provides a logical continuity for various aspects of TGFbeta biology and allows us to appreciate TGFbeta biology from a new perspective.

Citing Articles

Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies.

Sheikh K, Amjad M, Irfan M, Anjum S, Majeed T, Riaz M Onco Targets Ther. 2025; 18:233-262.

PMID: 39989503 PMC: 11846535. DOI: 10.2147/OTT.S493643.


Transcriptional activation of genes associated with the matrisome is a common feature of senescent endothelial cells.

Gonzalez I, Arredondo S, Maldonado-Agurto R Biogerontology. 2025; 26(2):59.

PMID: 39948317 PMC: 11825616. DOI: 10.1007/s10522-025-10191-5.


ADAM Metallopeptidase domain 19 promotes skin fibrosis in systemic sclerosis via neuregulin-1.

Meng Q, Bao D, Liu S, Huang J, Guo M, Dai B Mol Med. 2024; 30(1):269.

PMID: 39716051 PMC: 11665244. DOI: 10.1186/s10020-024-01047-8.


Metalloproteinase inhibitors regulate biliary progenitor cells through sDLK1 in organoid models of liver injury.

Defamie V, Aliar K, Sarkar S, Vyas F, Shetty R, Reddy Narala S J Clin Invest. 2024; 135(3).

PMID: 39699962 PMC: 11785925. DOI: 10.1172/JCI164997.


Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.

Crowley L, Stockley R, Thickett D, Dosanjh D, Scott A, Parekh D Eur Respir Rev. 2024; 33(174).

PMID: 39603661 PMC: 11600124. DOI: 10.1183/16000617.0139-2024.